The Valley Desk

Healthcare research from Johnson & Johnson, page 28

A filtered view. Show the full list.

Refine

817 publications and 7 software projects · listings 649–672

Listings

  1. Clinical trial reportThe New England journal of medicine

    Teclistamab plus Daratumumab in Relapsed or Refractory Multiple Myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  2. Clinical trial reportThe New England journal of medicine

    Dual Targeting of Extramedullary Myeloma with Talquetamab and Teclistamab

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  3. ArticleProceedings of the National Academy of Sciences of the United States of America

    Mitochondrial DNA lineages determine tumor progression through T cell reactive oxygen signaling

    Verified Author affiliations on the Europe PMC record name Children’s Hospital of Philadelphia, Johnson & Johnson, Perelman School of Medicine, University of Pennsylvania. Affiliation source

    Disease researchAdded

  4. ArticleCurrent medical research and opinion

    Drivers and barriers to health-seeking behaviors and interactions: a qualitative study of Black patients with lung cancer and with peripheral artery disease

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  5. ArticleCurrent medical research and opinion

    Patient and caregiver insights into lung cancer treatment decision-making: an exploratory focus group

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  6. ArticleCurrent medical research and opinion

    Real-world prevalence of potential drug-drug interactions associated with oral advanced therapies indicated for ulcerative colitis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  7. Clinical trial reportCurrent medical research and opinion

    Assessment of patient-reported depression severity in subpopulation of ESCAPE-TRD study: esketamine nasal spray versus quetiapine extended release for treatment-resistant depression

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  8. ArticleCurrent medical research and opinion

    Exacerbation and myasthenic crisis in generalized myasthenia gravis: real-world healthcare resource utilization and cost burden in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  9. ArticleCurrent medical research and opinion

    Differences in treatment decision-making for non-small cell lung cancer among patients and physicians, by race and ethnicity

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  10. ArticleLeukemia & lymphoma

    Treatment-emergent peripheral neuropathy associated with bortezomib-based frontline regimens for multiple myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  11. ArticleJournal of biopharmaceutical statistics

    Joint modeling of longitudinal endpoints and its applications to trial planning, monitoring and analysis

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Research dataAdded

  12. LetterDrug delivery

    Letter to the Editor regarding 'Evaluating nurse preferences for a novel on-body delivery system vs. manual syringes for large-volume subcutaneous drug administration: a survey study'

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  13. ArticleJournal of medical economics

    Cost per responder for teclistamab and elranatamab in relapsed or refractory multiple myeloma in the United States

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  14. ArticleJournal of medical economics

    Healthcare resource utilization and costs among patients with metastatic castration-sensitive prostate cancer initiated on apalutamide or enzalutamide in the United States (2019-2023)

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  15. ArticleJournal of medical economics

    Net present value cost analysis for treating retinitis pigmentosa

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  16. ArticleOphthalmic genetics

    Social media-derived patient perspectives on the burden of inherited retinal diseases, including retinitis pigmentosa

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Disease researchAdded

  17. ArticleOphthalmic genetics

    The timing of genetic testing and healthcare costs associated with the diagnostic journey of inherited retinal disease

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  18. ArticleFuture oncology (London, England)

    Burden of illness among patients with relapsed or refractory multiple myeloma, and eligible for B-cell maturation antigen-targeted therapies

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Public healthAdded

  19. ArticleFuture oncology (London, England)

    Community hematologist/oncologist perspectives on minimal residual disease testing in patients with multiple myeloma

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  20. ArticleFuture oncology (London, England)

    Fixed-duration ibrutinib-venetoclax for first-line treatment of patients with chronic lymphocytic leukemia: the REALITY-WW prospective real-world study cohort

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Clinical careAdded

  21. ArticleBioanalysis

    2024 White Paper on Recent Issues in Bioanalysis: Evolution of Immunogenicity Assessment beyond ADA/NAb; Regulated Genomic/NGS Assays; Hypersensitivity Reactions; Minimum Noise Reduction; False Positive Range; Modernized Vaccine Approaches; NAb/TAb Correlation (PART 3A - Recommendations on Advanced Strategies for Molecular Assays and Immunogenicity of Gene Therapy, Cell Therapy, Vaccine; Biotherapeutics Immunogenicity Assessment & Clinical Relevance PART 3B - Regulatory Agencies' Input on Immunogenicity/Technologies of Biotherapeutics, Gene, Cell & Vaccine Therapies)

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  22. ArticleBioanalysis

    2024 White paper on recent issues in bioanalysis: Impact of LDT in US and IVDR in EU; AI/ML for High Parameter Flow Cytometry; The rise of Olink Technology; CDx for AAV Gene Therapies; Integrative Bioanalysis by Multiple Platforms; Super Sensitive ADA/NAb LBA (PART 2A - Recommendations on Advanced Strategies for Biomarkers, IVD/CDx Assays (BAV), Cell Based Assays (CBA), and Ligand-Binding Assays (LBA) PART 2B - Regulatory Agencies' Input on Biomarkers, IVD/CDx, and Biomarker Assay Validation)

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  23. ArticleBioanalysis

    2024 White Paper on Recent Issues in Bioanalysis: Three Way-Cross Validation; Urine Clinical Analysis; Automated Methods; Regulatory Queries on Plasma Protein Binding; Automated Biospecimen Management; ELN Migration; Ultra-Sensitivity Mass Spectrometry (Part 1A - Recommendations on Advanced Strategies for Mass Spectrometry Assays, Chromatography, Sample Preparation and BMV/Regulated Bioanalysis Part 1B - Regulatory Agencies' Inputs on Regulated Bioanalysis/BMV)

    Verified Author affiliations on the Europe PMC record name Bristol Myers Squibb, GSK, Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded

  24. ArticleBioanalysis

    Simultaneous quantification of siRNA antisense and sense strands by hybrid liquid chromatography-mass spectrometry

    Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

    Biomedical and life sciencesAdded